These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6393337)

  • 1. [Advances in drug design].
    Guo ZR
    Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):238-44. PubMed ID: 6393337
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value and limitations of pharmacokinetics].
    Bogaert M
    Verh K Acad Geneeskd Belg; 1986; 48(4):221-4. PubMed ID: 3788268
    [No Abstract]   [Full Text] [Related]  

  • 4. Flexible drug molecules and dynamic receptors.
    Williams RJ
    Angew Chem Int Ed Engl; 1977 Nov; 16(11):766-77. PubMed ID: 412440
    [No Abstract]   [Full Text] [Related]  

  • 5. The QSAR paradigm in the design of less toxic molecules.
    Hansch C
    Drug Metab Rev; 1984-1985; 15(7):1279-94. PubMed ID: 6398775
    [No Abstract]   [Full Text] [Related]  

  • 6. [The biochemistry of toxic effects].
    Jacyszyn K
    Folia Med Cracov; 1987; 28(1-2):47-60. PubMed ID: 3623325
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimizing the potential for metabolic activation as an integral part of drug design.
    Evans DC; Baillie TA
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):44-50. PubMed ID: 15679171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 10. Starting from scratch.
    Chapman T
    Nature; 2004 Jul; 430(6995):113. PubMed ID: 15229610
    [No Abstract]   [Full Text] [Related]  

  • 11. Immobilized and insolubilized drugs, hormones, and neurotransmitters: properties, mechanisms of action and applications.
    Venter JC
    Pharmacol Rev; 1982 Jun; 34(2):153-87. PubMed ID: 6125955
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in biocatalytic synthesis of pharmaceutical intermediates.
    Panke S; Wubbolts M
    Curr Opin Chem Biol; 2005 Apr; 9(2):188-94. PubMed ID: 15811804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-pharmacokinetic relationships and drug design.
    Seydel JK; Schaper KJ
    Pharmacol Ther; 1981; 15(2):131-82. PubMed ID: 6124012
    [No Abstract]   [Full Text] [Related]  

  • 14. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical chronopharmacology].
    Markiewicz A
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1611-4. PubMed ID: 6687238
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thoughts on the development of drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):676-97. PubMed ID: 4576436
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronopharmacology and optimisation of dosage schedule.
    Doshi BS
    Indian J Physiol Pharmacol; 1981; 25(3):253-8. PubMed ID: 7298150
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uses and limits of radiotracers in the study of drugs and xenobiotics metabolism (author's transl)].
    Cohen Y
    Ann Pharm Fr; 1980; 38(3):279-94. PubMed ID: 6999962
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens: introduction.
    NIDA Res Monogr; 1978; (22):1-5. PubMed ID: 101878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.